Nanocarriers and Their Loading Strategies

Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma

Penetration of the blood–brain barrier (BBB) and the blood–brain tumor barrier (BBTB) remains a significant challenge for the delivery of drugs in the treatment of glioma. Therefore, the development of targeted preparations with the ability to penetrate the BBB and BBTB, and target gliomas, is an important approach if we are to improve the efficacy of glioma treatment. In the current study, an active targeting preparation based on PLGA nanoparticles coated with erythrocyte membranes (RBCNPs) and dual-modified with ^DWSW and NGR peptide ligands (^DWSW/NGR-RBCNPs). Euphorbia factor L1 (EFL1) extracted from euphorbiae semen was used as the model drug. The final nanoparticles were characterized by in vivo and in vitro tests. In vitro results showed that EFL1-loaded ^DWSW/NGR-RBCNPs were taken up by cells and had the ability to penetrate the BBB and BBTB and produce cytotoxic effects. Furthermore, in vivo studies in mice showed that when injected intravenously, these specialized NPs could enter the brain, target tumor tissue, and significantly extend life span. The results showed that dual-targeting EFL1-loaded ^DWSW/NGR-RBCNPs have significant potential as a nanotherapeutic tool for the treatment of brain glioma.

Sequential drug release via chemical diffusion and physical barriers enabled by hollow multishelled structures

Hollow multishelled structures (HoMSs), with relatively isolated cavities and hierarchal pores in the shells, are structurally similar to cells. Functionally inspired by the different transmission forms in living cells, we studied the mass transport process in HoMSs in detail. In the present work, after introducing the antibacterial agent methylisothiazolinone (MIT) as model molecules into HoMSs, we discover three sequential release stages, i.e., burst release, sustained release and stimulus-responsive release, in one system. The triple-shelled structure can provide a long sterility period in a bacteria-rich environment that is nearly 8 times longer than that of the pure antimicrobial agent under the same conditions. More importantly, the HoMS system provides a smart responsive release mechanism that can be triggered by environmental changes. All these advantages could be attributed to chemical diffusion- and physical barrier-driven temporally-spatially ordered drug release, providing a route for the design of intelligent nanomaterials.

Bowl-Shaped Polydopamine Nanocapsules: Control of Morphology via Template-Free Synthesis

Synthesis of hollow polydopamine bowl-shaped nanoparticles (nanobowls), as small as 80 nm in diameter, via a one-pot template-free rapid method is reported. Addition of dopamine to a solution of 0.606 mg/mL tris(hydroxymethyl)aminomethane in an ethanol/water mixed solvent resulted in the formation of hollow spherical nanocapsules within 2 h. At longer reaction times, the formation of conventional solid nanospheres dominated the reaction. The wall thickness of the nanocapsules increased with increasing dopamine concentration in the reaction medium. Wall thickness was also influenced by oxygen availability during the reaction. Nanocapsules with thin walls were prone to collapse. When dried, over 90% of the nanocapsules with wall thickness on the order of 11 nm collapsed. Also, the degree of collapse of individual nanoparticles changed from complete to partial to no collapse as the wall thickness was increased. Varying the ethanol content affected the cavity size and overall dimension of the nanocapsules produced but did not result in a significant change to the wall thickness. A mechanism describing the formation of the nanocapsules and their subsequent collapse into nanobowls is presented. The shape-tunable nanobowls prepared through this green, rapid, and affordable method are expected to have applications in the biomedical, electrochemical, and catalytic fields.

Thermo-Sensitive Dual-Functional Nanospheres with Enhanced Lubrication and Drug Delivery for the Treatment of Osteoarthritis

Osteoarthritis is a typical degenerative joint disease related to a lubrication deficiency of articular cartilage, which is characterized by increased friction at the joint surface and severe inflammation of the joint capsule. Consequently, therapies combining lubrication restoration and drug intervention are regarded as a promising strategy for the treatment of osteoarthritis. In the present study, thermo-sensitive dual-functional nanospheres, poly[N-isopropylacrylamide-2-methacryloyloxyethyl phosphorylcholine] (PNIPAM-PMPC), are developed through emulsion polymerization. The PNIPAM-PMPC nanospheres could enhance lubrication based on the hydration lubrication mechanism by forming a tenacious hydration layer surrounding the zwitterionic headgroups, and achieve local drug delivery by encapsulating the anti-inflammatory drug diclofenac sodium. The lubrication and drug release tests showed improved lubrication and thermo-sensitive drug release of the nanospheres. The in vitro test using cytokines-treated chondrocytes indicated that the PNIPAM-PMPC nanospheres were biocompatible and upregulated anabolic genes and simultaneously downregulated catabolic genes of the articular cartilage. In summary, the developed PNIPAM-PMPC nanospheres, with the property of enhanced lubrication and local drug delivery, can be an effective nanomedicine for the treatment of osteoarthritis.

Degradable pH-responsive NIR-II imaging probes based on a polymer-lanthanide composite for chemotherapy

In this research, a pH-sensitive degradable nanoprobe was designed by combining hydrophobic rare earth nanoparticles with biocompatible mPEG-PLGA nanomicelles for near infrared II (NIR-II) imaging-guided anti-tumor chemotherapy. The as-synthesized nanoprobes (about 300 nm) with a highly enhanced permeability and retention (EPR) effect show great potential in the diagnosis of solid tumors, providing new prospects for clinical tumor diagnosis. Then, the degradable composite probes increase the imaging sensitivity of the probe and allow for the slow release of the internal anti-tumor drugs, reducing the loss of the drug during delivery. Finally, ultra-small rare earth nanoparticles (about 6 nm) can be excreted after hydrolysis of the composite probe to reduce the enrichment of the inorganic nanoparticles in vivo. Thus, this degradable NIR-II imaging probe based on a polymer-lanthanide composite could be a promising candidate for preclinical cancer chemotherapy and surgery navigation under a single 808 nm laser.

TMEM16A-inhibitor loaded pH-responsive nanoparticles: A novel dual-targeting antitumor therapy for lung adenocarcinoma

To overcome the adverse effects of conventional chemotherapy for cancers, various nanoparticles based drug delivery systems have been developed. However, nanoparticles delivering drugs directly to kill tumor cells still faced with challenges, because tumors possessed adopt complex mechanism to resist damages, which compromised the therapeutic efficacy. TMEM16A/CaCCs (Calcium activates chloride channels) has been identified to be overexpressed in lung adenocarcinoma which can serve as a novel tumor specific drug target in our previous work. Here, we developed a novel dual-targeted antitumor strategy via designing a novel nano-assembled, pH-sensitive drug-delivery system loading with specific inhibitors of TMEM16A against lung adenocarcinoma. For validation, we assayed the novel dual-targeting therapy on xenograft mouse model which exhibited significant antitumor activity and not affect mouse body weight. The dual targeting therapy accomplished in this study will shed light on the development of advanced antitumor strategy.

Direct silica coating of drug crystals for ultra-high loading

To push the limit of synthetic control, we create a thin layer (5 nm) of silica on the surface of drug nanocrystals, achieving a loading content (88%) that approaches the theoretical limit. The uniform silica shell provides a tailored diffusion barrier for controlled drug release. The method can be generally applied to 11 organic crystals, including 4 drugs.

Construction of selenium-embedded mesoporous silica with improved antibacterial activity

In this work, different concentrations of Se-incorporated mesoporous silica nanospheres (MSNs) (5Se/MSNs and 10Se/MSNs) were successfully synthesized via an in-situ one-pot method. Their physicochemical properties were characterized by X-ray diffraction (XRD), transmission electron microscopy, and X-ray photoelectron spectroscopy (XPS). The release behaviors of Se and Si were investigated in a phosphate-buffered saline (pH = 5.5, 7.4) solution (PBS). In vitro antibacterial properties of the prepared samples were evaluated with Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). The cytocompatibilities of the samples were then assessed using L929 cells. Se nanoparticles were successfully loaded onto the outer and inner surfaces of hierarchical mesoporous silica. The sizes of the Se/MSNs nanoparticles were approximately 120 nm for 5Se/MSNs and 210 nm for 10Se/MSNs. The XRD and XPS results showed that Se mainly existed in the form of Se⁰ in the samples. The Se/MSNs exhibited stable and sustained release of both Si and Se in PBS solution. In vitro antibactericidal tests indicated that the Se/MSNs could exhibit better antibacterial activity against S. aureus than pure Se nanoparticles after 6 and 24 h of culturing. The minimal inhibitory concentration (MIC) of 10Se/MSN was 100 μg mL^-1. However, the Se/MSNs exhibited no inhibitory effect on E. coli bacteria. Furthermore, all the samples exhibited excellent cell viability. These studies demonstrate initial in vitro antibacterial activity and good cytocompatibility of Se/MSNs and their potential application in antibacterial nanomedicine.

Design, Synthesis and Self-Assembly of Functional Amphiphilic Metallodendrimers

A new family of alkynylated, amphiphilic dendrimers consisting of amidoamine linkers connected to 5,5'-functionalized 2,2'-bipyridine cores has been developed and evaluated in the formation of metallodendrimers of different generations and in self-assembly protocols. A convergent synthetic strategy was applied to provide dumbbell-shaped amphiphilic dendrimers, where the 2,2'-bipyridine cores could be coordinated to FeII centers to afford corresponding metallodendrimers. The ability of the metallic- and non-metallic dendritic structures to self-assemble into functional supramolecular aggregates were furthermore evaluated in aqueous solution. Spherical aggregates with sizes of a few hundred nanometers were generally produced, where controlled disassembly of the metallodendrimers through decomplexation could be achieved.